Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An update from Lifecare AS ( (DE:LFC0) ) is now available.
Lifecare ASA has reminded investors that the exercise period for its Warrant Series 1, issued in connection with a partially underwritten rights issue completed in January 2026, runs from 2 March to 13 March 2026, after which any unexercised warrants will lapse without value. The company also disclosed that insider-linked Teigland Eiendom AS has exercised 4,787,552 warrants for 1,600,000 new shares at NOK 0.3342 per share, with the resulting share capital increase expected to be registered around 25 March and new shares delivered around 26 March, implying potential dilution for warrant holders who do not participate.
More about Lifecare AS
Lifecare ASA is a medical sensor company specializing in technology for sensing and monitoring various body analytes in humans and pets. The company focuses on developing next-generation continuous glucose monitoring systems, using osmotic pressure as its core sensing principle to detect a wide range of analytes and molecules.
Average Trading Volume: 2,931,799
Current Market Cap: NOK69.55M
See more data about LFC0 stock on TipRanks’ Stock Analysis page.